Orris

A patient with st segment depression in leads V2 to V4 , aspirin has been given , What is the most appropriate next step in management of this patient? a)low molecular weight heparin b) thrombolytic c) angioplasty d)ii b /III a inhibitors e)metoprolol

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
The textbook confirms the answer clearly. Here is the full explanation:

Answer: A) Low Molecular Weight Heparin (LMWH)

Why this presentation = NSTE-ACS (UA/NSTEMI)

ST-segment depression in leads V2-V4 (rather than elevation) indicates subendocardial ischemia - this is the ECG hallmark of Unstable Angina (UA) or NSTEMI, NOT STEMI. This distinction drives the entire management algorithm.

Why LMWH is the correct next step

Aspirin has already been given (antiplatelet #1). The immediate next step per ACC/AHA guidelines is antithrombin therapy, and LMWH (e.g., enoxaparin 1 mg/kg SC twice daily) is the preferred agent:
  • More reliable anticoagulation with predictable pharmacokinetics compared to unfractionated heparin (UFH)
  • Greater anti-Xa activity
  • Lower risk of heparin-induced thrombocytopenia (HIT)
  • In the ESSENCE trial, enoxaparin + aspirin reduced death, MI, and recurrent angina more than UFH + aspirin (19.8% vs. 23.3%, P = 0.016) in UA/NSTEMI patients
  • A meta-analysis of 22,000 patients confirmed enoxaparin is superior to UFH for preventing death or MI
(Textbook of Family Medicine 9e, p. 677)

Why the other options are wrong

OptionWhy incorrect
B - ThrombolyticsContraindicated in NSTE-ACS. Thrombolytics are only for STEMI (ST elevation or new LBBB). In UA/NSTEMI, they increase bleeding risk without benefit - studies showed harm.
C - Angioplasty (PCI)Not the immediate next step. PCI is considered after risk stratification (TIMI score) and initial medical stabilization. Emergent PCI is reserved for refractory ischemia despite medical therapy, not the first move.
D - GP IIb/IIIa inhibitorsThese (e.g., tirofiban, eptifibatide) are considered upstream only in high-risk features, recurrent ischemia, or as an adjunct during PCI - not the first-line next step after aspirin alone.
E - MetoprololBeta-blockers are part of acute management but are an adjunct, not the single most important next step. They are used for rate control and reducing myocardial oxygen demand, but anticoagulation takes priority after aspirin.

Summary of Acute NSTE-ACS Management (in order)

  1. Aspirin (already given) - antiplatelet
  2. LMWH / UFH - antithrombin (the answer here)
  3. Clopidogrel (or other P2Y12 inhibitor) - second antiplatelet
  4. Beta-blocker (e.g., metoprolol) - reduce O2 demand
  5. Nitrates - symptom relief
  6. Statin - plaque stabilization
  7. Risk stratify (TIMI score) → decide on invasive vs. conservative strategy
The answer is A - Low Molecular Weight Heparin.
This is a shared conversation. Sign in to Orris to start your own chat.